Cheplapharm Arzneimittel Gmb
Cheplapharm Arzneimittel GmbH is a German specialty pharmaceutical enterprise headquartered in Greifswald, Germany. The company specializes in acquiring, registering, and globally commercializing established, well-known prescription pharmaceutical brands from major research-based pharmaceutical corporations. Its product portfolio encompasses established therapeutics across cardiology, oncology, neurology, and metabolic disorders. Principal revenue is derived through international wholesale pharmaceutical sales of its acquired medication portfolio to healthcare distributors and pharmacies. The enterprise operates an extensive global distribution network across over a hundred countries. Cheplapharm Arzneimittel GmbH issues debt instruments listed on financial exchanges.
8 of the funds FundTelligence covers report a position in Cheplapharm Arzneimittel Gmb.
- Sector
- Health Care
- Country
- Germany
- Funds holding it
- 8
Funds holding Cheplapharm Arzneimittel Gmb
- Nordea European High Yield Sustainable Stars Bond Fund — Nordea Funds · 1.66 % (full portfolio disclosed, September 2026)
- Nordea European High Yield Bond II — Nordea Funds · 1.65 % (full portfolio disclosed, September 2026)
- Nordea European High Yield Credit — Nordea Funds · 1.65 % (full portfolio disclosed, September 2026)
- Nordea European High Yield Bond — Nordea Funds · 0.59 % (full portfolio disclosed, September 2026)
- Nordea European High Yield Opportunities — Nordea Funds · 0.54 % (full portfolio disclosed, September 2026)
- Nordea PM Kreditobligationer — Nordea Funds · 0.28 % (full portfolio disclosed, September 2026)
- Alfred Berg Global High Yield — Alfred Berg · 0.13 % (full portfolio disclosed, June 2026)
- Nordea Global High Yield Enhanced Bond Fund — Nordea Funds · 0.12 % (full portfolio disclosed, September 2026)